Russell P Saneto Selected Research

Gabapentin (Neurontin)

8/2015

Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Russell P Saneto Research Topics

Disease

15	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2006
15	Seizures (Absence Seizure) 01/2022 - 11/2006
9	Epilepsy (Aura) 09/2021 - 04/2010
4	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2020 - 01/2012
3	Drug Resistant Epilepsy 01/2022 - 01/2014
3	Spasm (Spasms) 11/2019 - 12/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 05/2020
2	Leigh Disease (Leigh's Disease) 01/2021 - 08/2010
2	Infantile Spasms (West Syndrome) 12/2017 - 02/2009
2	Diffuse Cerebral Sclerosis of Schilder (Alpers' Disease) 01/2016 - 03/2013
1	Iron Deficiencies 01/2022
1	Dystonia (Limb Dystonia) 01/2022
1	Ataxia (Dyssynergia) 01/2021
1	Nausea 05/2020
1	Dyskinesias (Dyskinesia) 05/2020
1	Hydrocephalus (Hydrocephaly) 05/2020
1	Stroke (Strokes) 11/2019
1	Infarction (Infarctions) 11/2019
1	Pontocerebellar Hypoplasia Type 6 01/2019
1	Atrophy 01/2018
1	Neuralgia (Stump Neuralgia) 08/2015
1	Restless Legs Syndrome (Restless Legs) 08/2015
1	Deglutition Disorders (Dysphagia) 01/2014
1	Disease Progression 03/2013
1	Neoplasms (Cancer) 10/2012
1	Brain Neoplasms (Brain Tumor) 10/2012
1	Status Epilepticus (Complex Partial Status Epilepticus) 07/2012
1	Wounds and Injuries (Trauma) 07/2012
1	Liver Failure 01/2012
1	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 06/2010
1	Infections 01/2010
1	MELAS Syndrome (Syndrome, MELAS) 01/2006
1	Lactic Acidosis 01/2006
1	Muscle Weakness 01/2006
1	Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy) 01/2006

Drug/Important Bio-Agent (IBA)

9	Mitochondrial DNA (mtDNA)IBA 01/2021 - 01/2006
4	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020 - 07/2012
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
3	Valproic Acid (Depakote)FDA LinkGeneric 01/2012 - 01/2010
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2010
2	Vigabatrin FDA Link 12/2017 - 02/2009
2	Levetiracetam (Keppra)FDA LinkGeneric 10/2017 - 08/2015
2	DNA Polymerase gammaIBA 04/2013 - 01/2010
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2022
1	triheptanoinIBA 01/2022
1	ElementsIBA 01/2022
1	IronIBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2021
1	Metoclopramide (Reglan)FDA LinkGeneric 05/2020
1	CannabidiolIBA 01/2020
1	alpha-tocotrienol quinoneIBA 01/2019
1	Phospholipases (Phospholipase)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	CalciumIBA 01/2018
1	Prednisolone (Predate)FDA LinkGeneric 12/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2017
1	Gabapentin (Neurontin)FDA LinkGeneric 08/2015
1	1- (((alpha- isobutanoyloxyethoxy)carbonyl)aminomethyl)- 1- cyclohexaneacetic acidIBA 08/2015
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 08/2015
1	ProdrugsIBA 08/2015
1	Topiramate (Topamax)FDA LinkGeneric 08/2015
1	Lamotrigine (Lamictal)FDA LinkGeneric 08/2015
1	stiripentolIBA 09/2013
1	TEMPOIBA 03/2013
1	SolutionsIBA 10/2012
1	von Willebrand FactorIBA 07/2012
1	Midazolam (Versed)FDA LinkGeneric 07/2012
1	Diazepam (Valium)FDA LinkGeneric 07/2012
1	rufinamide FDA Link 04/2009
1	Biomarkers (Surrogate Marker)IBA 12/2007
1	Growth Hormone (Somatotropin)IBA 01/2006
1	Leu Transfer RNAIBA 01/2006

Therapy/Procedure

6	Therapeutics 11/2019 - 02/2009
3	Hemispherectomy 09/2021 - 01/2014
2	Ketogenic Diet 01/2022 - 02/2015
2	Vagus Nerve Stimulation 07/2007 - 11/2006
1	Ventriculostomy 05/2020
1	Organ Transplantation 01/2016
1	Transplantation 01/2016
1	High-Protein Low-Carbohydrate Diet (Atkins Diet) 02/2015
1	Electrodes (Electrode) 06/2013
1	Radiotherapy 10/2012
1	Aftercare (After-Treatment) 10/2012
1	Drug Therapy (Chemotherapy) 10/2012